Cimetidine
ADVERTISEMENT
- Molecular formula
- C10H16Cl2N6S
- CAS Number
- 51481-61-9
- IUPAC Name
- 1-[amino-(3,4-dichloroanilino)methylene]-2-isopropyl-guanidine
- Molecular Weight
- 252.34g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.1682g/cm3
- Synonyms
- N-(3, 4-Dichlorophenyl)-N'-(1-methylethyl)imidodicarbonimidic Diamide Hydrochloride, 1-(3, 4-Dichlorophenyl)-5-isopropylbiguanide, Chloroproguanil Hydrochloride, N1-3, 4-Dichlorophenyl-N5-isopropyldiguanide Hydrochloride, M 5943
Identification
Interesting facts
Interesting Facts about 1-[amino-(3,4-dichloroanilino)methylene]-2-isopropyl-guanidine
This intriguing compound is notable for its multifaceted role in various scientific fields, particularly medicinal chemistry. Here are some enlightening points to consider:
- Biological Significance: Composed of a guanidine core, this compound has been investigated for its potential pharmacological properties, particularly in the regulation of blood glucose levels.
- Structure-Activity Relationship: The introduction of the 3,4-dichloroanilino group plays a crucial role in enhancing the activity of the molecule, highlighting the importance of chemical modifications in drug design.
- Research Applications: Studies have suggested its utility in diabetes management, making it a subject of interest for researchers striving to develop innovative therapeutic agents.
- Mechanism of Action: While the exact mechanisms remain under exploration, compounds like this have the potential to influence specific pathways involved in insulin signaling.
- Synergistic Properties: When combined with other therapies, the unique properties of this compound could lead to synergistic effects, improving treatment efficacy for various conditions.
As you delve into the fascinating world of chemical compounds, the study of 1-[amino-(3,4-dichloroanilino)methylene]-2-isopropyl-guanidine serves as a prime example of how tinkering with molecular architecture can lead to groundbreaking advancements in healthcare and medicine.